Edison Investment Research - THEON INTERNATIONAL PLC (THEON) Theon International - Positive update on FY24

Report

Edison Investment Research

Toby Thorrington

Theon International - Positive update on FY24

Theon is a market leader in night vision and thermal imaging systems. The group has released a positive update on FY24 and further order intake for Q4, providing momentum into FY25. The latest events in the Middle East are likely to support military budgets globally. This will provide a positive environment for Theon that will be supplemented by internal development to expand the product portfolio to support integrated battlefield requirements.

09/12/2024 1 EN

Underlying

THEON INTERNATIONAL PLC

See profile

CY0200751713 Cyprus

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Analysts

Toby Thorrington

Other Reports on these Companies

Edison Investment Research

Theon International - Record order book and upgrade to FY25

Theon International is a market leader in the defence optronics (night vision and thermal imaging) sector. Strong order intake, particularly in Q424, has enabled management to provide a positive outlook for FY25, including c 20% revenue growth. Adding in the mid-20% operating margins, we see the shares offering clear attractions on the current undemanding P/E rating of 11x in FY25e.

January 2, 2025 January 2, 2025 1 EN

Edison Investment Research

Theon International - Clear vision for growth

Theon International commands a unique position in military night vision systems as a market-leading business focused on man-portable systems (goggles). It has a market-leading position in Europe, an expanding presence globally and is developing adjacent product portfolios, most notably platforms like military vehicle vision systems. Its potential is supported by an addressable market of more than €3bn forecast to grow at double-digit rates. Combining this with a low capital-intensity business model should drive positive financials and strong cash generation.

November 25, 2024 November 25, 2024 1 EN

Mendus - Regulatory endorsement supports vididencel focus

Mendus’s lead asset, vididencel, is fast approaching the pivotal stages of development in acute myeloid leukaemia (AML), with recent endorsements from both the FDA and EMA (on the design of the planned registrational trial). Separately, Mendus has decided to cease further development for its second asset, ilixadencel, after the termination of its collaboration agreement with Institut Bergonié, sponsor of the REGOMUNE trial. We note that the termination was due to this basket study being prematurely halted, and not specifically related to ilixadencel. We view Mendus’s new streamlined approach t...

January 3, 2025 January 3, 2025 1 EN

Toby Thorrington

Toby Thorrington

Melrose Industries - Fundamentals remain positive

The aerospace sector outlook remains positive, with lengthy order books at the primes (Airbus and Boeing) and total passenger flying hours in 2024 on schedule to exceed post-pandemic levels, supporting a strong aftermarket. The former will assist margin recovery for Melrose Industries’ original equipment (OE) operations, while increased flying hours are already generating strong growth and margin in the aftermarket business. Hence, our adjustment to estimates for external factors, such as FX movements, should not detract investors from focusing on the underlying positive dynamics of the busine...

January 2, 2025 January 2, 2025 1 EN

Toby Thorrington

Toby Thorrington

Theon International - Record order book and upgrade to FY25

January 2, 2025 January 2, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Theon International - Positive update on FY24

Theon International - Record order book and upgrade to FY25

Theon International - Clear vision for growth

Mendus - Regulatory endorsement supports vididencel focus

Melrose Industries - Fundamentals remain positive

Theon International - Record order book and upgrade to FY25

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe